Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESONAR study of rituximab in active rheumatoid arthritis refractory to anti-TNF therapy
2008-002381-55Phase 4Terminated
- Sponsor
- Roche
- Start
- Aug 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, double-blind trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Primary endpoint: Mean change in RAMRIS score at 6 months. Started Aug 2008; status: terminated.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2008-002381-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002381-55.